Elevated hepatocyte growth factor levels in osteoarthritis osteoblasts contribute to their altered response to bone morphogenetic protein-2 and reduced mineralization capacity

E. Abed (1) , B. Bouvard (2, 3) , X. Martineau (1) , J.-Y. Jouzeau (2, 4) , P. Reboul (2) , D. Lajeunesse (1)

1 CHUM - Centre Hospitalier de l'Université de Montréal
2 IMoPA - Ingénierie Moléculaire et Physiopathologie Articulaire
3 Service de rhumatologie
4 Service de Pharmacologie Clinique et Toxicologie [CHRU Nancy]

Domaines: Sciences du Vivant [q-bio]

E. Abed, B. Bouvard, X. Martineau, J.-Y. Jouzeau, P. Reboul, et al.. Elevated hepatocyte growth factor levels in osteoarthritis osteoblasts contribute to their altered response to bone morphogenetic protein-2 and reduced mineralization capacity. BONE, 2015, 75, pp.111-119. ⟨10.1016/j.bone.2015.02.001⟩. ⟨hal-02921974⟩